Clinical trial Recruiting at 1 site Interventional Ages 3 to 17

Easy-to-Read Visual Health Materials for Children and Teens with Intellectual Disabilities

Official title: Integrated Program for Promoting Visual Health and Technological Applications for Individuals With Intellectual Disabilities

Run by National Taiwan University Hospital · NCT07036575 · Data updated 2026-11-12

This program will try easy-to-read and audio-based eye health materials plus a digital screening tool to improve visual health for children and adolescents with intellectual disabilities.

More Visual Impairment trials

Quick facts

Study typeInterventional
Ages3 Years to 17 Years
SexAll
Enrollment250 (estimated)
SponsorNational Taiwan University Hospital
Academic / other
Locations1 site (Taipei)
StatusRecruiting
StartedJune 2025
Main results expectedJune 2026
Study endsDecember 2026
Registry record updatedJune 25, 2025
Trial IDNCT07036575 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children and adolescents aged 3 to under 18 with intellectual disabilities or developmental delays who can identify at least two of three images in the pre-assessment and can attend sessions at participating centers.

Probably not a fit

Children with severe cognitive impairment, uncorrected hearing loss, significant speech disorders, or motor disabilities that prevent participation in assessments or instructional activities are unlikely to benefit from the interventions.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This integrated program develops accessible health materials, a digital visual screening system, and healthcare-access tools tailored for children and adolescents with intellectual disabilities. The study will recruit 250 participants aged 3 to under 18 and collect baseline information including the Vineland Adaptive Behavior Scales and age-appropriate developmental tests such as the Mullen Scales for younger children. Participants will receive either standard visual health education, instructor-guided easy‑read education, or easy‑read audio self-learning while the digital screening platform is implemented and refined. Outcomes include participant comprehension and usability of materials, feasibility of the screening tool, and rates of identified ophthalmologic concerns.

Why it matters

Potential benefit: If successful, the program could increase understanding of eye care and lead to earlier detection and treatment of vision problems for children with intellectual disabilities.

How similar studies have gone: Previous work has shown that easy-read and audio materials can improve comprehension and engagement in people with intellectual disabilities, but applying those methods to a tailored digital visual screening program is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Children and adolescents aged 3 to under 18
* Children and adolescents with intellectual disabilities and developmental delays.
* Children and adolescents who are able to correctly identify at least two out of the three images in the pre-assessment phase.

Exclusion Criteria:

* Severe cognitive impairments, hearing impairments, speech disorders, or motor disabilities that would interfere with assessment procedures or participation in the instructional activities.

Where it's running

  • Intellectual and developmental disability centers and related institutions
    Taipei, Taiwan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.